AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 41 min read$THC

West Nadja sold $298K of THC

West Nadja sold 1,152 shares of TENET HEALTHCARE CORP (THC) at $258.80 ($0.30M total) on 2026-09-02.

Original reporting
SEC EDGAR · West Nadja
Published Sep 4, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$THC
Neutral
medium confidence
Mentioned
$THC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCNeutralLow
01

Why it matters

The transaction is a primary disclosure but modest in scale, likely causing limited price movement.

02

Market read

Insider sale provides fresh data for traders monitoring THC but is unlikely to drive major market moves.

03

What to watch

Potential upcoming corporate actions or personal tax considerations not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-02, reported 2026-09-03

Background

Form 4 filing by a director discloses a recent open‑market sale of company stock.

Company-level read

Ticker impact

$THCNeutralMedium confidence
Context

Director West Nadja sold 1,152 shares for $298,137, reducing her stake to 23,653 shares.

Expected impact

Potential slight downward pressure on THC price in short term.

Evidence & confidence

Sale amount is under $300k and represents a small percentage of holdings; market reaction likely limited.

Market effects

Sector

Minimal impact on healthcare sector; insider sales are routine.

Regional

No significant regional effect.

Global

Limited relevance beyond the specific stock.

Counterpoint

What could challenge this read

The sale could be unrelated to confidence and merely portfolio rebalancing.

Key entities

  • Company
    Tenet Healthcare Corp.

    US‑listed healthcare services provider (ticker THC).

  • Director
    West Nadja

    Director of Tenet Healthcare who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

THC insider trading history →

Related articles

SEP 9
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders

Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.

simplywall.st2 min
SEP 9
$THCMedAI 8/10

Tenet Healthcare at Wells Fargo conference: high-acuity push deepens

Tenet Healthcare (THC) presented at the Wells Fargo Healthcare Conference, outlining a strategy focused on high-acuity care, capital spending, and cost control. The company raised full-year guidance, citing volume growth and cost discipline. Shares are near their 52-week high at $268.82, up over 30% year-to-date. Tenet expects continued pressure in some payer channels and near-term earnings drag from Conifer's transition. Management plans to invest in complex procedures and maintain capital spen

uk.investing.com2 min